Hubei, China

Xiaofei Yan

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaofei Yan. Retrieved from https://idiyas.com/inventor/xiaofei-yan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaofei Yan

Introduction

Xiaofei Yan is a notable inventor based in Hubei, China. He has made significant contributions to the field of chemistry, particularly in the development of heterocyclic compounds. His work has implications for various applications in pharmaceuticals and materials science.

Latest Patents

Xiaofei Yan holds a patent for heterocyclic compounds. The invention provides new heterocyclic compounds having the general formula (IA), wherein A, L, X, Y, m, n, R, and R are as described in the patent. This patent includes compositions comprising the compounds, processes for manufacturing the compounds, and methods for using the compounds. He has 1 patent to his name.

Career Highlights

Xiaofei Yan is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role involves research and development, focusing on innovative solutions in the pharmaceutical industry. His expertise in heterocyclic chemistry has positioned him as a valuable asset to his team.

Collaborations

Throughout his career, Xiaofei has collaborated with esteemed colleagues such as Joerg Benz and Uwe Grether. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Xiaofei Yan's contributions to the field of chemistry, particularly through his patent on heterocyclic compounds, highlight his innovative spirit and dedication to advancing science. His work continues to influence the pharmaceutical industry and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…